Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., Dagenais G.Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med2000;342:145-53.
2.
Leu HB, Charng MJ, Ding PYA double blind randomized trial to compare the effects of eprosartan and enalapril on blood pressure, platelets, and endothelium function in patients with essential hypertension. Jpn Heart J2004;45:623-35.
3.
Pitt B., Poole-Wilson P., Segal R. et al. Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study-ELITE II. J Card Fail1999;5:146-54.
Sumukadas D. , Witham MD, Struthers AD, McMurdo MEAre elderly people with the HOPE criteria prescribed angiotensin-converting enzyme inhibitors?JRAAS2004;5:26.
